Literature DB >> 30658248

Measuring multivariate risk preferences in the health domain.

Arthur E Attema1, Olivier l'Haridon2, Gijs van de Kuilen3.   

Abstract

We investigate univariate and multivariate risk preferences for health (longevity) and wealth. We measure attitudes toward correlation and attitudes toward higher order dependence structures such as cross-prudence and cross-temperance, making use of the risk apportionment technique proposed by Eeckhoudt et al. (2007). For multivariate gains, we find correlation aversion and cross-prudence in longevity and wealth. For losses, we observe correlation seeking and cross-imprudence. We do not find clear evidence for cross-temperance. Our results indicate that longevity and wealth are considered to be substitutes for gains, but not for losses. Second, univariate (higher order) risk preferences are comparable for longevity and wealth, although somewhat closer to linearity for wealth. Third, we find evidence that attitudes toward dependence structures in the health domain are sign-dependent.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Health; Multivariate risk attitudes; Prudence; Temperance

Mesh:

Year:  2018        PMID: 30658248     DOI: 10.1016/j.jhealeco.2018.12.004

Source DB:  PubMed          Journal:  J Health Econ        ISSN: 0167-6296            Impact factor:   3.883


  3 in total

1.  On the effect of uncertainty on personal vaccination decisions.

Authors:  Christophe Courbage; Richard Peter
Journal:  Health Econ       Date:  2021-08-03       Impact factor: 2.395

2.  Multivariate risk preferences in the quality-adjusted life year model.

Authors:  Arthur E Attema; Jona J Frasch; Olivier L'Haridon
Journal:  Health Econ       Date:  2021-11-18       Impact factor: 2.395

3.  Eliciting risk preferences that predict risky health behavior: A comparison of two approaches.

Authors:  Murong Yang; Laurence S J Roope; James Buchanan; Arthur E Attema; Philip M Clarke; A Sarah Walker; Sarah Wordsworth
Journal:  Health Econ       Date:  2022-02-22       Impact factor: 2.395

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.